Kiora Pharmaceuticals Inc (KPRX) stock
KPRXNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as KPHMW
$0.82−0.11 (-11.31%)
Close on Nov 18, 2026Market cap $3.65MP/E –Yield –
Kiora Pharmaceuticals free cash flow
Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.
Kiora Pharmaceuticals's free cash flow for the twelve months ending Jun 30, 2026 was -$8.61M. For fiscal 2025 it was -$10.07M, down 217.8% from the year before. The highest annual figure on record is $8.55M in fiscal 2024.
Annual free cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$10.07M | -217.8% |
| FY2024 | Dec 31, 2024 | $8.55M | – |
| FY2023 | Dec 31, 2023 | -$9.56M | – |
| FY2022 | Dec 31, 2022 | -$10.43M | – |
| FY2021 | Dec 31, 2021 | -$10.74M | – |
| FY2020 | Dec 31, 2020 | -$7.34M | – |
| FY2019 | Dec 31, 2019 | -$8.15M | – |
| FY2018 | Dec 31, 2018 | -$10.86M | – |
| FY2017 | Dec 31, 2017 | -$6.51M | – |
| FY2016 | Dec 31, 2016 | -$8.41M | – |
Quarterly free cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$1.92M | – |
| Q1 FY2026 | Mar 31, 2026 | -$3.17M | – |
| Q4 FY2025 | Dec 31, 2025 | -$2.26M | – |
| Q3 FY2025 | Sep 30, 2025 | -$1.27M | -238.4% |
| Q2 FY2025 | Jun 30, 2025 | -$3.84M | – |
| Q1 FY2025 | Mar 31, 2025 | -$2.70M | – |
| Q4 FY2024 | Dec 31, 2024 | -$2.21M | – |
| Q3 FY2024 | Sep 30, 2024 | $920.06K | – |
| Q4 FY2023 | Dec 31, 2023 | -$2.58M | – |
| Q3 FY2023 | Sep 30, 2023 | -$2.52M | – |
| Q4 FY2021 | Dec 31, 2021 | -$2.92M | – |
| Q3 FY2021 | Sep 30, 2021 | -$2.27M | – |
| Q2 FY2021 | Jun 30, 2021 | -$2.92M | – |
| Q1 FY2021 | Mar 31, 2021 | -$2.63M | – |
| Q4 FY2019 | Dec 31, 2019 | -$2.59M | – |
| Q4 FY2018 | Dec 31, 2018 | -$2.00M | – |
| Q4 FY2017 | Dec 31, 2017 | -$1.49M | – |
See a number that looks wrong?